title: Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases.
abstract: Owing to the worldwide obesity epidemic and the sedentary lifestyle in industrialized countries, the number of people with metabolic diseases is explosively increasing. Magnetic resonance spectroscopy (MRS), which is fundamentally similar to magnetic resonance imaging, can detect metabolic changes in vivo noninvasively. With its noninvasive nature, (1)H, (13)C and (31)P MRS are being actively utilized in clinical and biomedical metabolic studies to detect lipids and important metabolites without ionizing radiation. (1)H MRS can quantify lipid content in liver and muscle and can detect other metabolites, such as 2-hydroxyglutarate, in vivo. Of interest, many studies have indicated that hepatic and intramyocellular lipid content is inversely correlated with insulin sensitivity in humans. Thus, lipid content can be utilized as an in vivo biomarker for detecting early insulin resistance. Employing (13)C MRS, hepatic glycogen synthesis and breakdown can be directly detected, whereas (31)P MRS provides in vivo adenosine triphosphate (ATP) synthesis rates by saturation transfer methods in addition to ATP content. These in vivo data can be very difficult to assess by other methods and offer a critical piece of metabolic information. To aid the reader in understanding these new methods, fundamentals of MRS are described in this review in addition to promising future applications of MRS and its limitations.
authors: Korea Mouse Metabolic Phenotyping Center (KMMPC), Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.
authors: Jong-Hee
authors: JH
authors: Hwang
authors: 1] Korea Mouse Metabolic Phenotyping Center (KMMPC), Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea [2] Division of Endocrinology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
authors: Cheol Soo
authors: CS
authors: Choi
mesh_terms: D066241:Carbon-13 Magnetic Resonance Spectroscopy; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008659:Metabolic Diseases / Q000175:diagnosis*; D010759:Phosphorus Isotopes; D011522:Protons
chemical_list: D010759:Phosphorus Isotopes; D011522:Protons
references: Cardiovasc Diabetol. 2013 Apr 15;12:65
references: 23587409
references: J Magn Reson B. 1994 Jun;104(2):189-92
references: 8049871
references: NMR Biomed. 2003 May;16(3):160-7
references: 12884360
references: J Cereb Blood Flow Metab. 2012 Dec;32(12):2108-13
references: 22990416
references: Brain. 1997 Oct;120 ( Pt 10):1699-711
references: 9365364
references: Diabetes. 2006 Mar;55(3):659-66
references: 16505228
references: Science. 2003 May 16;300(5622):1140-2
references: 12750520
references: Nat Med. 2012 Jan 26;18(4):624-9
references: 22281806
references: N Engl J Med. 2004 Feb 12;350(7):664-71
references: 14960743
references: NMR Biomed. 1993 Sep-Oct;6(5):302-10
references: 8268062
references: Am J Physiol. 1999 May;276(5):E977-89
references: 10329993
references: Diabetologia. 1999 Jan;42(1):113-6
references: 10027589
references: Magn Reson Imaging. 1996;14(10):1217-20
references: 9065913
references: Biophys J. 1988 Nov;54(5):921-9
references: 3242635
references: J Clin Invest. 1996 Feb 1;97(3):642-8
references: 8609218
references: J Appl Physiol (1985). 2003 Sep;95(3):1105-15
references: 12754181
references: N Engl J Med. 1999 Jul 22;341(4):240-6
references: 10413736
references: J Clin Invest. 1995 Feb;95(2):783-7
references: 7860761
references: J Physiol. 1998 Jul 15;510 ( Pt 2):615-22
references: 9706008
references: Gerontology. 2011;57(5):387-96
references: 20798481
references: Magn Reson Med. 2007 Jan;57(1):103-14
references: 17191226
references: N Engl J Med. 1990 Jan 25;322(4):223-8
references: 2403659
references: J Biol Chem. 1976 May 10;251(9):2584-91
references: 4452
references: Clin Orthop Relat Res. 1989 Jul;(244):3-6
references: 2663289
references: NMR Biomed. 2011 Oct;24(8):943-57
references: 21882281
references: Magn Reson Med. 2014 May;71(5):1670-5
references: 23798380
references: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2724-8
references: 9122264
references: Magn Reson Med. 2013 Sep;70(3):620-9
references: 23023916
references: J Clin Invest. 1992 Apr;89(4):1069-75
references: 1556176
references: J Lipid Res. 2008 Sep;49(9):2055-62
references: 18509197
references: J Clin Invest. 1969 Jul;48(7):1313-27
references: 5794253
references: Diabetes Care. 2011 Feb;34(2):448-53
references: 21216854
references: Nature. 1982 Feb 18;295(5850):608-9
references: 6799841
references: Hepatology. 2009 Oct;50(4):1079-86
references: 19637187
references: Magn Reson Med. 2014 Jun;71(6):1959-72
references: 23843330
references: Dig Dis. 2010;28(1):203-9
references: 20460912
references: Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1169-77
references: 17711988
references: Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19926-31
references: 19066218
references: Proc Natl Acad Sci U S A. 1976 Dec;73(12):4446-8
references: 12507
references: Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1663-9
references: 17911339
references: J Lipid Res. 2008 Feb;49(2):473-80
references: 18024705
references: Prog Lipid Res. 1995;34(3):199-217
references: 8685239